CALCITONIN SECRETION IN POSTMENOPAUSAL OSTEOPOROSIS

被引：114
|
作者：
TIEGS, RD
BODY, JJ
WAHNER, HW
BARTA, J
RIGGS, BL
HEATH, H
机构：
[1] MAYO CLIN & MAYO FDN,DEPT MED,DIV ENDOCRINOL & METAB,ENDOCRINE RES SECT,ROCHESTER,MN 55905
[2] MAYO MED SCH,ROCHESTER,MN 55901
[3] MAYO CLIN & MAYO FDN,DEPT LAB MED,DIV DIAGNOST NUCL MED,ROCHESTER,MN 55905
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1985年 / 312卷 / 17期
关键词：
D O I：
10.1056/NEJM198504253121705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
  • [31] CALCITONIN SECRETION AND POST-MENOPAUSAL OSTEOPOROSIS
    STEVENSON, JC
    WHITEHEAD, MI
    LANCET, 1982, 1 (8275): : 804 - 804
  • [32] EFFECTS OF ESTROGENS AND CALCIUM ON CALCITONIN SECRETION IN POSTMENOPAUSAL WOMEN
    BODY, JJ
    STRUELENS, M
    BORKOWSKI, A
    MANDART, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (01): : 223 - 226
  • [33] ORAL ALENDRONATE AND INTRANASAL CALCITONIN IN THE TREATMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
    ADAMI, S
    LOMBARDI, A
    ORTOLANI, S
    PASSERI, M
    CAPIZZI, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S254 - S254
  • [34] Treatment of osteoporosis in postmenopausal women: Alendronate vs intranasal calcitonin
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    Palmisano, J
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S197 - S197
  • [35] The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis
    Colpan, L
    Gur, A
    Cevik, R
    Nas, K
    Sarac, AJ
    MATURITAS, 2005, 51 (03) : 246 - 253
  • [36] Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis
    İ Tekeoğlu
    B Adak
    M Budancamanak
    A Demirel
    L Ediz
    Rheumatology International, 2005, 26 : 157 - 161
  • [37] Effects of 2-year treatment with calcitonin in postmenopausal osteoporosis
    Gurer, G.
    Sendur, O. F.
    Tastaban, E.
    Aydemir, A. H.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S261 - S261
  • [38] Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis
    Body, JJ
    BONE, 2002, 30 (05) : 75S - 79S
  • [39] Long term treatment of postmenopausal osteoporosis with calcitonin, alendronate, or alphacalcidiol
    Demirel, GG
    Paker, N
    Yilmaz, H
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S181 - S181
  • [40] Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis
    Tekeoglu, I
    Adak, B
    Budancamanak, M
    Demirel, A
    Ediz, L
    RHEUMATOLOGY INTERNATIONAL, 2005, 26 (02) : 157 - 161
12345